NICOCCINO GET ENHANCED AND EXTENDED PATENT PROTECTION

Intellectual Property Office of Singapore is the first authority to approve the
Company’s own nicotine patent which is based on the previous platform patent
that Nicoccino uses through licensing. The platform patent is so far approved in
eleven countries and holds a protection until 2026. The new nicotine patent
provides an enhanced protection until 2033.
- ”It is very gratifying that it is Singapore that approves the patent as it is
a reputable and respected body. Being able to both enhance and extend the
protection of our product in Nicoccino’s own name creates additional value to
the Company”, says Johan Cram, CEO for Nicoccino Holding.

The platform patent is so far approved in Sweden, US, China, Russia, Japan,
Austria, New Zeeland, South Africa, Israel, South Korea and Canada. Nicoccino
has submitted the application for nicotine patent in additional fifteen
countries and in the EU.

For more information, visit Nicoccino‘s website www.nicoccino.se, or contact:

Johan Cram, CEO

+46 708 980 418

johan.cram@nicoccino.se

About Nicoccino Holding AB

Nicoccino develops and markets a patented, innovative and discrete nicotine
product that instantly provides the user with nicotine without the detrimental
side effects of traditional tobacco products. The product has the same name as
the company – Nicoccino™ – and is manufactured through partners.

The Nicoccino Holding share is listed on Nasdaq Stockholm First North under the
ticker NICO.

Remium Nordic AB is Nicocino Holding's Certified Adviser.